The structure and biological properties of (4-hydroxy-1-methyl-2-oxo-1,2-dihydro-quinolin-3-yl)acetic acid and its esters
DOI:
https://doi.org/10.24959/ophcj.13.754Keywords:
4-hydroxy-2-oxo-1, 2-dihydroquinolines, hetarylacetic acids, complex esters, X-ray diffraction analysis, anti-inflammatory action, analgesic activityAbstract
Continuing the search of new effective and safe means for pain relief in the range of different derivatives of 4-hydroxyquinoline-2-ones (4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinolin-3-yl)acetic acid and series of its alkyl esters have been involved in the objects of our research. All pharmacological experiments in studying the anti-inflammatory and analgesic activity of the compounds synthesized have been carried out in white mice using standard screening models – «carrageenan edema» and «acetic acid writhing», respectively. Compounds that are not inferior to the anti-exudative and analgesic action of the known non-steroidal anti-inflammatory drug Diclofenac have been identified. In addition, the important structural and biological regularities, which are of interest for further research as a starting basis have been found. With the help of X-ray analysis the peculiarities of the spatial structure of some products synthesized have been studied. A detailed comparative analysis of X-ray diffraction data of the most active analgesics identified among the tested substances – methyl (4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinolin-3-yl) acetate and its ethyl analogue has been performed. It is instrumentally confirmed that these two compounds have a substantially identical spatial structure, the same type of the intermolecular hydrogen bonds system and the same crystalline packing. However, they exhibit an analgesic effect approximately of the same level, but vary greatly in intensity of their anti-inflammatory properties. According to the results of the comprehensive analytical and biological studies the conclusion has been made that for all its undoubted importance the crystalline structure of substances is not the only factor that has a significant impact on their pharmacological properties.
Downloads
References
- Kleemann A., Engel J., Kutscher B., Reichert D. Pharmaceutical Substances: Syntheses, Patents, Applications of the most relevant APIs; 5th Revised edition. – Stuttgart: Thieme, 2008. – 1800 p.
- Машковский М.Д. Лекарственные средства. – М.: РИА «Новая волна»: Издатель Умеренков, 2008. – 1206 с.
- Collin X., Robert J.M., Duflos M. et al. // J. Pharm. Pharmacol. – 2001. – Vol. 53, №3. – P. 417-423.
- Ukrainets I.V., Davidenko A.A., Mospanova E.V. et al. // Chem. Heterocycl. Comp. – 2010. – Vol. 46, №5. – P. 559-568.
- Ukrainets I.V., Mospanova E.V., Davidenko A.A., Shishkina S.V. // Chem. Heterocycl. Comp. – 2010. – Vol. 46, №9. – P. 1084-1095.
- Ukrainets I.V., Bevz O.V., Mospanova E.V. et al. // Chem. Heterocycl. Comp. – 2012. – Vol. 48, №2. – P. 320-326.
- Ukrainets I.V., Gorokhova O.V., Andreeva X.V., Sim G. // Int. J. Pharm. Pharmacol. – 2012. – Vol. 1, №3. – P. 34-40.
- Ukrainets I.V., Gorokhova O.V., Andreeva K.V., Kravchenko V.N. // Chem. Heterocycl. Comp. – 2012. – Vol. 48, №12. – P. 1809-1816. – DOI: 10.1007/s10593-013-1213-5
- Ukrainets I.V., Gorokhova O.V., Andreeva K.V. // Russ. J. Org. Chem. – 2013. – Vol. 49, №6. – P. 867-871.
- Ukrainets I.V., Mospanova E.V., Davidenko A.A. et al. // Chem. Heterocycl. Comp. – 2010. – Vol. 46, №8. – P. 947-956.
- Vogel H.G. Drug Discovery and Evaluation: Pharmacological Assays. – Berlin: Springer; 2008. – 2071 p.
- Сигидин Я.А., Шварц Г.Я., Арзамасцев А.П., Либерман С.С. Лекарственная терапия воспалительного процесса. – М.: Медицина, 1988. – С. 60-63.
- Зефиров Ю.В. // Кристаллография. – 1997. – Т. 42, №5. – C. 936-958.
- Burgi H.-B., Dunitz J.D. Structure correlation. – Weinheim: VCH, 1994. – Vol. 2. – P. 741-784.
- Ukrainets I.V., Shishkina S.V., Shishkin O.V. et al. // Acta Crystallogr. Sect. E. – 2009. – Vol. E65. – P. o968.
- Ukrainets I.V., Mospanova E.V., Davidenko А.А., Shishkina S.V. // Chem. Heterocycl. Comp. – 2010. – Vol. 46, №11. – P. 1371-1379.
- Українець І.В., Моспанова О.В., Гріневич Л.О., Колісник О.В. // Медична хімія. – 2010. – Т. 12, №2 (43). – С. 68-72.
- Украинец И.В., Моспанова Е.В., Баумер В.Н. // ЖОФХ. – 2012. – Т. 10, вып. 1 (37). – С. 66-71.
- Sheldrick G.M. // Acta Crystallogr., Sect. A. – 2008. – Vol. A64. – P. 112-122.
- Shishkina S.V., Shishkin O.V., Ukrainets I.V., Mospanova E.V. // Acta Crystallogr. Sect. E. – 2010. – Vol. E66. – P. o3195.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2013 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:
1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.
3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).